SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fernando D. Testai, Hao-Liang Xu, John Kilkus, Vidyani Suryadevara, Irina Gorshkova, Evgeny Berdyshev, Dale A. Pelligrino, Glyn Dawson, Changes in the metabolism of sphingolipids after subarachnoid hemorrhage, Journal of Neuroscience Research, 2015, 93, 4
  2. 2
    Hao-Liang Xu, Dale A Pelligrino, Chanannait Paisansathan, Fernando D Testai, Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage, Journal of Neuroinflammation, 2015, 12, 1

    CrossRef

  3. 3
    Jilin Bai, Patrick D. Lyden, Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema, International Journal of Stroke, 2015, 10, 2
  4. 4
    Fatemeh Safarian, Behzad Khallaghi, Abolhassan Ahmadiani, Leila Dargahi, Activation of S1P1 Receptor Regulates PI3K/Akt/FoxO3a Pathway in Response to Oxidative Stress in PC12 Cells, Journal of Molecular Neuroscience, 2014,

    CrossRef

  5. 5
    Xabier Urra, Francesc Miró, Angel Chamorro, Anna M. Planas, Antigen-specific immune reactions to ischemic stroke, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  6. 6
    Rana Omidbakhsh, Banafshe Rajabli, Sanaz Nasoohi, Behzad Khallaghi, Zahurin Mohamed, Murali Naidu, Abolhassan Ahmadiani, Leila Dargahi, Fingolimod affects gene expression profile associated with LPS-induced memory impairment, Experimental Brain Research, 2014, 232, 11, 3687

    CrossRef

  7. 7
    Lei Lu, Arnavaz Hajizadeh Barfejani, Tao Qin, Qiang Dong, Cenk Ayata, Christian Waeber, Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage, Brain Research, 2014, 1555, 89

    CrossRef

  8. 8
    Robert Brunkhorst, Rajkumar Vutukuri, Waltraud Pfeilschifter, Fingolimod for the treatment of neurological diseases—state of play and future perspectives, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  9. 9
    Victor Voon, Lavanya Saiva, Sara O’Kelly, David Keane, Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis – insights into possible drug mechanism, European Journal of Clinical Pharmacology, 2014, 70, 3, 373

    CrossRef

  10. 10
    Min Wang, Lin Lu, Yehong Liu, Gang Gu, Rong Tao, FTY720 attenuates hypoxia–reoxygenation-induced apoptosis in cardiomyocytes, Experimental and Molecular Pathology, 2014, 97, 2, 218

    CrossRef

  11. 11
    Stine Mencl, Nelli Hennig, Sarah Hopp, Michael K. Schuhmann, Christiane Albert-Weissenberger, Anna-Leena Sirén, Christoph Kleinschnitz, FTY720 does not protect from traumatic brain injury in mice despite reducing posttraumatic inflammation, Journal of Neuroimmunology, 2014, 274, 1-2, 125

    CrossRef

  12. 12
    Peter Kraft, Kerstin Göbel, Sven G Meuth, Christoph Kleinschnitz, Glatiramer acetate does not protect from acute ischemic stroke in mice, Experimental & Translational Stroke Medicine, 2014, 6, 1, 4

    CrossRef

  13. 13
    Ying Fu, Ningnannan Zhang, Li Ren, Yaping Yan, Na Sun, Yu-Jing Li, Wei Han, Rong Xue, Qiang Liu, Junwei Hao, Chunshui Yu, Fu-Dong Shi, Impact of an immune modulator fingolimod on acute ischemic stroke, Proceedings of the National Academy of Sciences, 2014, 111, 51, 18315

    CrossRef

  14. 14
    T. Bucky Jones, Lymphocytes and autoimmunity after spinal cord injury, Experimental Neurology, 2014, 258, 78

    CrossRef

  15. 15
    Javier Vargas-Medrano, Sesha Krishnamachari, Ernesto Villanueva, Wesley H. Godfrey, Haiyan Lou, Ramesh Chinnasamy, Jeffrey B. Arterburn, Ruth G. Perez, Novel FTY720-Based Compounds Stimulate Neurotrophin Expression and Phosphatase Activity in Dopaminergic Cells, ACS Medicinal Chemistry Letters, 2014, 5, 7, 782

    CrossRef

  16. 16
    Takashi Shichita, Minako Ito, Akihiko Yoshimura, Post-ischemic inflammation regulates neural damage and protection, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  17. 17
    Joanna Pyszko, Joanna B. Strosznajder, Sphingosine Kinase 1 and Sphingosine-1-Phosphate in Oxidative Stress Evoked by 1-Methyl-4-Phenylpyridinium (MPP+) in Human Dopaminergic Neuronal Cells, Molecular Neurobiology, 2014, 50, 1, 38

    CrossRef

  18. 18
    L. Chicha, T. Smith, R. Guzman, Stem cells for brain repair in neonatal hypoxia–ischemia, Child's Nervous System, 2014, 30, 1, 37

    CrossRef

  19. 19
    Guanying Wang, Roy Y. Kim, Isabella Imhof, Norman Honbo, Fu S. Luk, Kang Li, Nikit Kumar, Bo-Qing Zhu, Delphine Eberlé, Daniel Ching, Joel S. Karliner, Robert L. Raffai, The Immunosuppressant FTY720 Prolongs Survival in a Mouse Model of Diet-induced Coronary Atherosclerosis and Myocardial Infarction, Journal of Cardiovascular Pharmacology, 2014, 63, 2, 132

    CrossRef

  20. 20
    Aijia Cai, Frieder Schlunk, Ferdinand Bohmann, Sepide Kashefiolasl, Robert Brunkhorst, Christian Foerch, Waltraud Pfeilschifter, Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke–no influence on functional outcome and blood–brain barrier disruption, Experimental & Translational Stroke Medicine, 2013, 5, 1, 11

    CrossRef

  21. 21
    Stephanie C. Tucker, Kenneth V. Honn, Emerging targets in lipid-based therapy, Biochemical Pharmacology, 2013, 85, 5, 673

    CrossRef

  22. 22
    Hiromi Noda, Hideyuki Takeuchi, Tetsuya Mizuno, Akio Suzumura, Fingolimod phosphate promotes the neuroprotective effects of microglia, Journal of Neuroimmunology, 2013, 256, 1-2, 13

    CrossRef

  23. 23
    Luisa Di Menna, Gemma Molinaro, Luigi Di Nuzzo, Barbara Riozzi, Cristina Zappulla, Carlo Pozzilli, Renato Turrini, Filippo Caraci, Agata Copani, Giuseppe Battaglia, Ferdinando Nicoletti, Valeria Bruno, Fingolimod protects cultured cortical neurons against excitotoxic death, Pharmacological Research, 2013, 67, 1, 1

    CrossRef

  24. 24
    William B. Rolland, Tim Lekic, Paul R. Krafft, Yu Hasegawa, Orhan Altay, Richard Hartman, Robert Ostrowski, Anatol Manaenko, Jiping Tang, John H. Zhang, Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage, Experimental Neurology, 2013, 241, 45

    CrossRef

  25. 25
    Masoumeh Asle-Rousta, Zeynab Kolahdooz, Shahrbanoo Oryan, Abolhassan Ahmadiani, Leila Dargahi, FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats, Journal of Molecular Neuroscience, 2013, 50, 3, 524

    CrossRef

  26. 26
    Monika Liguz-Lecznar, Malgorzata Kossut, Influence of Inflammation on Poststroke Plasticity, Neural Plasticity, 2013, 2013, 1

    CrossRef

  27. 27
    Walter Swardfager, Daniel A. Winer, Nathan Herrmann, Shawn Winer, Krista L. Lanctôt, Interleukin-17 in post-stroke neurodegeneration, Neuroscience & Biobehavioral Reviews, 2013, 37, 3, 436

    CrossRef

  28. 28
    Ji Woong Choi, Jerold Chun, Lysophospholipids and their receptors in the central nervous system, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013, 1831, 1, 20

    CrossRef

  29. 29
    Fatemeh Hemmati, Leila Dargahi, Sanaz Nasoohi, Rana Omidbakhsh, Zahurin Mohamed, Zamri Chik, Murali Naidu, Abolhassan Ahmadiani, Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine, Behavioural Brain Research, 2013, 252, 415

    CrossRef

  30. 30
    Hui Zhou, Song Li, Xinhuan Niu, Ping Wang, Junnan Wang, Mengyuan Zhang, Protective Effect of FTY720 Against Sevoflurane-Induced Developmental Neurotoxicity in Rats, Cell Biochemistry and Biophysics, 2013, 67, 2, 591

    CrossRef

  31. 31
    Yu Hasegawa, Hidenori Suzuki, Orhan Altay, William Rolland, John H. Zhang, Role of the Sphingosine Metabolism Pathway on Neurons Against Experimental Cerebral Ischemia in Rats, Translational Stroke Research, 2013, 4, 5, 524

    CrossRef

  32. 32
    Jens Minnerup, Antje Schmidt, Christiane Albert-Weissenberger, Christoph Kleinschnitz, Stroke: Pathophysiology and Therapy, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 2013, 5, 2, 1

    CrossRef

  33. 33
    Junfeng Liu, Canfei Zhang, Wendan Tao, Ming Liu, Systematic Review and Meta-Analysis of the Efficacy of Sphingosine-1-Phosphate (S1P) Receptor Agonist FTY720 (Fingolimod) in Animal Models of Stroke, International Journal of Neuroscience, 2013, 123, 3, 163

    CrossRef

  34. You have free access to this content34
    Kyra J. Becker, Activation of immune responses to brain antigens after stroke, Journal of Neurochemistry, 2012, 123,
  35. 35
    Erasmia Broussalis, Eugen Trinka, Monika Killer, Andrea Harrer, Mark McCoy, Jörg Kraus, Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies, Drug Discovery Today, 2012, 17, 13-14, 671

    CrossRef

  36. 36
    C. Kleinschnitz, N. Plesnila, Experimentelle Ansätze zur Therapie des ischämischen Schlaganfalls, Der Nervenarzt, 2012, 83, 10, 1275

    CrossRef

  37. 37
    Fei Gao, Yangfeng Liu, Xiaowei Li, Ying Wang, Dong Wei, Wen Jiang, Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model, Pharmacology Biochemistry and Behavior, 2012, 103, 2, 187

    CrossRef

  38. 38
    Yusuke Norimatsu, Tsukasa Ohmori, Atsushi Kimura, Seiji Madoiwa, Jun Mimuro, Atsushi Seichi, Yutaka Yatomi, Yuichi Hoshino, Yoichi Sakata, FTY720 Improves Functional Recovery after Spinal Cord Injury by Primarily Nonimmunomodulatory Mechanisms, The American Journal of Pathology, 2012, 180, 4, 1625

    CrossRef

  39. 39
    Tim Magnus, Heinz Wiendl, Christoph Kleinschnitz, Immune mechanisms of stroke, Current Opinion in Neurology, 2012, 25, 3, 334

    CrossRef

  40. 40
    Vanessa H Brait, Thiruma V Arumugam, Grant R Drummond, Christopher G Sobey, Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia, Journal of Cerebral Blood Flow & Metabolism, 2012, 32, 4, 598

    CrossRef

  41. 41
    Bradley K Wacker, Angela B Freie, Jennifer L Perfater, Jeffrey M Gidday, Junctional protein regulation by sphingosine kinase 2 contributes to blood–brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance, Journal of Cerebral Blood Flow & Metabolism, 2012, 32, 6, 1014

    CrossRef

  42. You have free access to this content42
    Takashi Shichita, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Akihiko Yoshimura, Hiroaki Ooboshi, Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke, Journal of Neurochemistry, 2012, 123,
  43. 43
    Qing Mei Wang, James K Liao, ROCKs as immunomodulators of stroke, Expert Opinion on Therapeutic Targets, 2012, 16, 10, 1013

    CrossRef

  44. 44
    Ruben van Doorn, Melissa A Lopes Pinheiro, Gijs Kooij, Kim Lakeman, Bert van het Hof, Susanne MA van der Pol, Dirk Geerts, Jack van Horssen, Paul van der Valk, Elizabeth van der Kam, Eric Ronken, Arie Reijerkerk, Helga E de Vries, Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier, Journal of Neuroinflammation, 2012, 9, 1, 133

    CrossRef

  45. 45
    Ángel Chamorro, Andreas Meisel, Anna M. Planas, Xabier Urra, Diederik van de Beek, Roland Veltkamp, The immunology of acute stroke, Nature Reviews Neurology, 2012, 8, 7, 401

    CrossRef

  46. 46
    Waltraud Pfeilschifter, Bożena Czech-Zechmeister, Marian Sujak, Ana Mirceska, Alexander Koch, Abdelhaq Rami, Helmuth Steinmetz, Christian Foerch, Andrea Huwiler, Josef Pfeilschifter, Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia, Biochemical and Biophysical Research Communications, 2011, 413, 2, 212

    CrossRef

  47. 47
    Keun-Hwa Jung, Challenges and Pitfalls of Stroke Therapeutics Research, Korean Journal of Stroke, 2011, 13, 1, 11

    CrossRef

  48. 48
    E. Ann Yeh, B. Weinstock-Guttman, Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis, Advances in Therapy, 2011, 28, 4, 270

    CrossRef

  49. 49
    Takashi Yoshino, Hiroko Tabunoki, Shigeo Sugiyama, Keitaro Ishii, Seung U. Kim, Jun-ichi Satoh, Non-phosphorylated FTY720 Induces Apoptosis of Human Microglia by Activating SREBP2, Cellular and Molecular Neurobiology, 2011, 31, 7, 1009

    CrossRef

  50. 50
    Gunnar P.H. Dietz, Protection by neuroglobin and cell-penetrating peptide-mediated delivery in vivo: A decade of research, Experimental Neurology, 2011, 231, 1, 1

    CrossRef

  51. 51
    A. Arac, S. E. Brownell, J. B. Rothbard, C. Chen, R. M. Ko, M. P. Pereira, G. W. Albers, L. Steinman, G. K. Steinberg, Systemic augmentation of  B-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation, Proceedings of the National Academy of Sciences, 2011, 108, 32, 13287

    CrossRef

  52. 52
    Hyung-Seok Kim, Man-Seok Park, Jeong-Kil Lee, Hye-Jeong Kim, Jong-Tae Park, Min-Cheol Lee, Time Point Expression of Apoptosis Regulatory Proteins in a Photochemically-Induced Focal Cerebral Ischemic Rat Brain, Chonnam Medical Journal, 2011, 47, 3, 144

    CrossRef

  53. 53
    Waltraud Pfeilschifter, Bożena Czech-Zechmeister, Marian Sujak, Christian Foerch, Thomas A Wichelhaus, Josef Pfeilschifter, Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice, Experimental & Translational Stroke Medicine, 2011, 3, 1, 2

    CrossRef

  54. 54
    Christian Waeber, Sphingosine 1-Phosphate (S1P) Signaling and the Vasculature,